Abbott Laboratories narrowed its full-year outlook as sales of COVID-19 tests slide. COVID-19 test sales in the second quarter dropped 46% from the year before. Second-quarter earnings and revenue ...

Abbott Laboratories gains attention as medical devices, diabetes care, cardiovascular products, and raised guidance ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

Abbott Laboratories, Inc. ABT recently announced the receipt of the FDA approval for the Alinity i laboratory traumatic brain injury (TBI) blood test. This will be the first commercially available TBI ...

Abbott Laboratories’ sales of COVID-19 tests fell by a whopping 89% during the second quarter of this year compared with the same time last year — a drop that comes as the world attempts to move on ...

Abbott Laboratories (NYSE:ABT) operates across healthcare sectors including devices, diagnostics, nutrition, and ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The North Chicago company said ...

Two years after Abbott landed FDA clearance for a hand-held blood test that could detect signs of mild traumatic brain injuries (TBIs) in the span of about 15 minutes, the concussion-spotting test is ...

Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street Abbott Laboratories (NYSE:ABT) reported second-quarter ...

Abbott Laboratories ABT is slated to report its second-quarter 2026 results on July 16, before the opening bell. The Zacks ...